Xellia Pharmaceuticals is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of anti-infective treatments aimed at combating serious and often life-threatening bacterial and fungal infections. With over 115 years of experience, Xellia stands as a world-leading and trusted supplier of several important established anti-infective drugs, including active pharmaceutical ingredients and injectable products. The company is evolving by generating an innovative pipeline of value-added anti-infective medicines designed to enhance patient care while ensuring reliable supply and consistent quality.

Services include:
– Finished Dosage Forms
– Active Pharmaceutical Ingredients
– Contract Manufacturing (CMO/CDMO)
– Generics/Biosimilars

Xellia Pharmaceuticals is committed to responsible manufacturing, production, and research and development that promote long-term sustainability in the pharmaceutical industry. For more information, please visit xellia.com.